Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain-Reference-Cited by-同舟云学术

Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain

Published:2015-08 Issue:2 Volume:46 Page:157-163
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Fernández-Martínez Marta,Miró Elisenda,Ortega Adriana,Bou Germán,González-López Juan José,Oliver Antonio,Pascual Alvaro,Cercenado Emilia,Oteo Jesús,Martínez-Martínez Luis,Navarro Ferran

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece;Galani;J Chemother,2012

2. Synthesis and spectrum of the neoglycoside ACHN-490;Aggen;Antimicrob Agents Chemother,2010

3. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data;Campos;J Antimicrob Chemother,2007

4. Spanish multicenter study of the epidemiology and mechanisms of amoxicillin–clavulanate resistance in Escherichia coli;Ortega;Antimicrob Agents Chemother,2012

5. Efflux-mediated multiresistance in Gram-negative bacteria;Poole;Clin Microbiol Infect,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic background of aminoglycoside-modifying enzymes in various genetic lineages of clinical aminoglycosides-resistant E. coli and K. pneumoniae isolates in Tunisia;Journal of Applied Microbiology;2024-07

2. Apramycin efficacy against carbapenem- and aminoglycoside-resistant Escherichia coli and Klebsiella pneumoniae in murine bloodstream infection models;International Journal of Antimicrobial Agents;2024-07

3. Apramycin efficacy in the treatment of carbapenem-resistantEnterobacteralesin murine blood stream infection models;2023-12-10

4. In vitro activity of apramycin against 16S-RMTase-producing Gram-negative isolates;Journal of Global Antimicrobial Resistance;2023-06

5. Whole-genome sequencing-based characteristics of Escherichia coli Rize-53 isolate from Turkey;Advances in Clinical and Experimental Medicine;2022-09-09